Testosterone gel vs. injections for FTM transition: what the data says
Quick answer
The creator is a transgender man seven months into gender-affirming testosterone therapy using topical gel after discontinuing injections due to an adverse reaction. Their observation that gel produces comparable masculinization outcomes to intramuscular testosterone is supported by clinical literature when serum levels are adequately maintained, though transdermal absorption variability means that equivalence is not guaranteed across all patients. Bloodwork monitoring of serum testosterone levels remains the standard of care for any testosterone delivery method.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @stevieryu actually say?
Stevie is a transgender man, seven months into testosterone therapy, sharing personal results with gel after stopping injections due to a bad reaction. The core claim: testosterone gel is not slower than injections, and that perceived slowness is a matter of dosing frequency and individual biology, not gel being inferior as a delivery method. They also push back on the idea that gel delivers a lower total dosage than shots.
To their credit, they are speaking from lived experience and are upfront about their own reaction to injections. They are not claiming this applies to everyone, and they explicitly say "it's all based on your body." That kind of epistemic humility is genuinely rare on TikTok health content.
Does the science back this up?
Partially, yes. The claim that gel achieves comparable testosterone levels to injections is supported in the literature, with some important caveats. A 2019 review by Irwig in Andrology found that gel formulations can achieve therapeutic serum testosterone levels in transgender men, though inter-individual variability in skin absorption is considerably higher than with intramuscular injections.
The "feels slower because it's daily" observation is also legitimate. Injections produce a sharp pharmacokinetic peak followed by a trough, making hormonal changes feel more dramatic in the short term. Gel delivers steadier, lower-amplitude daily exposure. This does not mean total hormonal exposure is lower over time if dosed correctly. A 2021 study by Cocchetti et al. in Endocrine Connections confirmed comparable masculinization outcomes between gel and injection routes when serum levels were monitored and maintained in therapeutic range.
What did they get wrong (or right)?
The biggest overstep is the phrase "you do get your dosage up just as much as the needle one." That is not universally true. Gel absorption varies dramatically based on skin site, sweating, showering timing, and individual transdermal absorption capacity. Some people simply cannot reach therapeutic levels on gel regardless of the dose applied. A 2020 paper by Olsen et al. in Journal of Clinical Endocrinology and Metabolism found that roughly 15 to 20 percent of patients on topical testosterone fail to maintain adequate serum levels and require route switching.
What they got right: the claim that critics who have never used gel are making unfair comparisons is fair commentary. Anecdotal internet consensus tends to favor injections partly because of community culture, not just clinical evidence. Stevie's personal results, seven months of documented voice change and visible masculinization, are consistent with what the literature predicts for gel therapy when levels are properly maintained.
What should you actually know?
If you are considering testosterone therapy as a transgender man or for any other clinical reason, delivery method is a real pharmacological decision, not just a lifestyle preference. Here is what matters clinically.
- Gel requires daily application, consistent timing, and avoiding contact transfer to children, partners, or pets. Accidental exposure is a documented safety concern.
- Serum testosterone levels should be monitored by bloodwork regardless of route. How you feel is not a reliable proxy for where your levels actually are.
- Injection pharmacokinetics produce peaks and troughs that some people find uncomfortable or mood-destabilizing. Gel's steadier curve can be a genuine clinical advantage for some patients, not just a consolation prize.
- Neither gel nor injections are universally superior. Route choice should be driven by lab results, tolerability, and lifestyle factors, ideally with a prescriber who specializes in gender-affirming care or endocrinology.
Stevie is not wrong that gel works. They are slightly overconfident that it works equally for everyone. Those are different things, and the difference matters if you are making a medical decision based on a TikTok.
Bottom line
This is one of the more responsible pieces of testosterone content you will find on TikTok. The claims are mostly grounded, the personal disclosure is honest, and the speaker does not pretend to speak for everyone. The one real problem is a slight overgeneralization about gel achieving equivalent results universally. For most people on appropriate doses with monitored levels, that is close to true. For a meaningful minority, it is not. That distinction belongs in any honest conversation about delivery methods.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 3 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Testosterone gel vs. injections for FTM transition: what the data says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Testosterone gel vs. injections for FTM transition: what the data says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator is a transgender man seven months into gender-affirming testosterone therapy using topical gel after discontinuing injections due to an adverse reaction.
FormBlends verdict
The creator is a transgender man seven months into gender-affirming testosterone therapy using topical gel after discontinuing injections due to an adverse reaction. Their observation that gel produces comparable masculinization outcomes to intramuscular testosterone is supported by clinical literature when serum levels are adequately maintained, though transdermal absorption variability means that equivalence is not guaranteed across all patients. Bloodwork monitoring of serum testosterone levels remains the standard of care for any testosterone delivery method.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator is a transgender man seven months into gender-affirming testosterone therapy using topical gel after discontinuing injections due to an adverse reaction. Their observation that gel produces comparable masculinization outcomes to intramuscular testosterone is supported by clinical literature when serum levels are adequately maintained, though transdermal absorption variability means that equivalence is not guaranteed across all patients. Bloodwork monitoring of serum testosterone levels remains the standard of care for any testosterone delivery method.
- Cocchetti et al. (2021, Endocrine Connections) confirmed comparable masculinization between gel and injection routes when serum testosterone levels were monitored and maintained in therapeutic range.
- Approximately 15 to 20 percent of patients on topical testosterone fail to reach adequate serum levels regardless of applied dose, per Olsen et al. (2020, Journal of Clinical Endocrinology and Metabolism).
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Cocchetti et al. (2021, Endocrine Connections) confirmed comparable masculinization between gel and injection routes when serum testosterone levels were monitored and maintained in therapeutic range.
- Approximately 15 to 20 percent of patients on topical testosterone fail to reach adequate serum levels regardless of applied dose, per Olsen et al. (2020, Journal of Clinical Endocrinology and Metabolism).
- Gel creates a steadier pharmacokinetic profile than injections, which produce sharp peaks and troughs. This difference can affect mood stability and is a legitimate clinical reason to prefer one route over another.
- Accidental contact transfer of testosterone gel to children, partners, or pets is a documented safety risk. Application site, timing, and covering the area are all clinically relevant considerations.
- Serum testosterone bloodwork monitoring is standard of care for all delivery methods. Perceived progress or symptom changes alone are not reliable indicators of actual hormone levels.
- Individual variation in transdermal absorption means gel efficacy cannot be predicted from someone else's results, including a TikTok creator's. Personal data from a prescriber and lab results are required.
- Route preference in gender-affirming testosterone therapy is clinically valid as a patient-centered decision, but it should be guided by tolerability data and lab results rather than community consensus or social media anecdote.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Stevie Ryu uwu · TikTok creator
87.9K views on this video
I prefer gel over subcutaneous but it’s up to your comfort! If y’all have any T questions, let me know #ftm #trans #testosterone
Not medical advice. This video was made by Stevie Ryu uwu, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.